Epigenomics Enrolls First Participant in its FIT Comparative Study with Epi proColon®
OneMedRadio interviewed Thomas Taapken, CFO of Epigenomics, a Berlin based molecular diagnostics company for the early detection of cancer.
4914
Copyright © 2025 | WordPress Theme by MH Themes